With three placements in the 2026 IP STARS Ranking – in the “Patent Prosecution” category and for the outstanding achievements of individual attorneys – WINTER BRANDL once again confirms its leading position in the German IP market. We are proud that our firm is listed as a Tier 3 firm …

  We are delighted that WINTER BRANDL has once again been recognized in the Handelsblatt ranking ‘Germany’s Best Lawyers‘ for 2026. This award reinforces our commitment to combining expertise with strategic precision—because innovation thrives best when protected with trust and clarity.

We proudly announce that WINTER BRANDL partner and patent attornies Michael Wieser, Alexander Kühn and Michael Wegerer are featured again in IAM Patent 1000: The World’s Leading Patent Professionals 2026. You can find the our company profile here. The IAM Patent 1000 is the definitive resource for identifying top patent professionals …

We are extremely pleased that WINTER BRANDL has been ranked by the Financial Times and Statista as one of Europe’s leading patent law firms in 2026 for the third consecutive year.

Dr. Alexander Wyrwoll, Partner/Patent Attorney at WINTER BRANDL is FICPI-Member of the Months for June 2026. He focuses on clear IP strategies that create measurable added value for clients. What he finds most satisfying about being an IP attorney: developing and implementing a clear IP strategy that creates measurable value …

At this year’s Annual Meeting of the International Trademark Association in London, the law firm Winter Brandl was represented by our partner Michael Wieser and attorney-at-law Michelle Brendjes. The focus was on current trends in trademark and patent protection, digital challenges, and international cooperation in the field of intellectual property. …

WINTER BRANDL patent attorney and head of the IP team for Chemistry & Biotechnology Clarissa Regler has been appointed as a member of FICPI’s CET Group 4 during the FICPI World Congress in Naples.

In a plenary vote on February 7, 2024, the European Parliament adopted a position supporting the Environment Committee’s proposal to ban patents on all plants obtained through new genomic techniques (NGT). However, such a patent ban would jeopardize Europe’s innovative strength and competitiveness in the field of plant biotechnology. Patents …